On 2025-05-05, AnaptysBio, Inc. (ANAB) announced earnings per share of $-1.28 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-1.30.
The next expected annoucement date for quarterly earnings is 2025-08-04, with an average estimated earnings per share of $-1.47 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
---|---|---|---|
2025-05-05 | 2025-03-31 | $-1.30 | $-1.28 |
2025-02-27 | 2024-12-31 | $-1.61 | $-0.72 |
2024-11-05 | 2024-09-30 | $-1.72 | $-1.14 |
2024-08-05 | 2024-06-30 | $-1.20 | $-1.71 |
2024-05-09 | 2024-03-31 | $-1.54 | $-1.64 |
2024-03-11 | 2023-12-31 | $-1.74 | $-1.59 |
2023-11-02 | 2023-09-30 | $-1.72 | $-1.41 |
2023-08-07 | 2023-06-30 | $-1.65 | $-1.50 |
2023-05-11 | 2023-03-31 | $-1.04 | $-1.58 |
2023-03-01 | 2022-12-31 | $-0.92 | $-0.93 |
2022-11-08 | 2022-09-30 | $-0.47 | $-1.18 |
2022-08-08 | 2022-06-30 | $-0.95 | $-1.15 |
2022-05-04 | 2022-03-31 | $-0.87 | $-1.31 |
2022-03-07 | 2021-12-31 | $2.28 | $-1.13 |
2021-11-04 | 2021-09-30 | $-0.74 | $-0.24 |
2021-08-09 | 2021-06-30 | $-0.15 | $-0.02 |
2021-05-04 | 2021-03-31 | $-0.71 | $-0.66 |
2021-02-25 | 2020-12-31 | $1.94 | $1.20 |
2020-11-04 | 2020-09-30 | $-0.77 | $-0.87 |
2020-08-10 | 2020-06-30 | $-0.75 | $-0.79 |
2020-05-06 | 2020-03-31 | $-0.64 | $-0.30 |
2020-03-02 | 2019-12-31 | $-1.27 | $-0.75 |
2019-11-08 | 2019-09-30 | $-1.12 | $-1.15 |
2019-08-08 | 2019-06-30 | $-0.93 | $-0.89 |
2019-05-07 | 2019-03-31 | $-0.75 | $-0.82 |
2019-02-28 | 2018-12-31 | $-0.91 | $-0.64 |
2018-11-08 | 2018-09-30 | $-0.69 | $-0.66 |
2018-08-07 | 2018-06-30 | $-0.71 | $-0.57 |
2018-05-08 | 2018-03-31 | $-0.44 | $-0.63 |
2018-03-05 | 2017-12-31 | $-0.41 | $-0.30 |
2017-11-07 | 2017-09-30 | $-0.46 | $-0.45 |
2017-08-10 | 2017-06-30 | $-0.44 | $-0.13 |
2017-05-11 | 2017-03-31 | $-0.25 | $-0.75 |